ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 54,357 | 52,887 | 57,122 | 50,703 | 47,268 |
| Cost of Goods | 15,632 | 14,725 | 20,133 | 15,605 | 16,593 |
| Gross Profit | 38,725 | 38,162 | 36,989 | 35,098 | 30,675 |
| Operating Expenses | 30,065 | 34,485 | 25,677 | 25,589 | 24,005 |
| Operating Income | 9,292 | 4,402 | 11,445 | 10,114 | 7,263 |
| Interest Expense | 3,406 | 3,354 | 3,626 | 3,768 | 3,730 |
| Other Income | 46 | -130 | -479 | 20 | -30 |
| Pre-tax Income | 5,932 | 918 | 7,340 | 6,366 | 3,503 |
| Income Tax | -653 | 469 | 1,910 | 1,329 | 726 |
| Net Income Continuous | 6,585 | 449 | 5,430 | 5,037 | 2,777 |
| Net Income | $6,585 | $449 | $5,430 | $5,037 | $2,777 |
| EPS Basic Total Ops | 0.55 | 0.04 | 0.45 | 0.43 | 0.24 |
| EPS Basic Continuous Ops | 0.56 | 0.04 | 0.46 | 0.43 | 0.24 |
| EPS Diluted Total Ops | 0.53 | 0.04 | 0.46 | 0.42 | 0.23 |
| EPS Diluted Continuous Ops | 0.54 | 0.04 | 0.46 | 0.43 | 0.24 |
| EBITDA(a) | $18,764 | $20,505 | $20,131 | $18,662 | $15,576 |